We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $4.85B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+144%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.85B
AUM Growth
+$462M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
69
New
Increased
Reduced
Closed

Top Buys

1
+$169M
2
+$140M
3
+$111M
4
GMAB icon
Genmab
GMAB
+$110M
5
VERA icon
Vera Therapeutics
VERA
+$55.4M

Top Sells

1
+$242M
2
+$125M
3
+$69.3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$67.1M
5
MAZE
Maze Therapeutics
MAZE
+$33.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPSC icon
51
Century Therapeutics
IPSC
$406M
$21.4M 0.44%
+9,487,745
BEAM icon
52
Beam Therapeutics
BEAM
$2.99B
$19.6M 0.4%
+820,765
CNTX icon
53
Context Therapeutics
CNTX
$128M
$19.4M 0.4%
7,419,355
PSNL icon
54
Personalis
PSNL
$1B
$19.1M 0.39%
+3,000,000
JANX icon
55
Janux Therapeutics
JANX
$827M
$16.5M 0.34%
1,187,290
+1,097,701
PMN icon
56
ProMIS Neurosciences
PMN
$92.8M
$10.6M 0.22%
+835,655
CBIO
57
Crescent Biopharma
CBIO
$494M
$8.33M 0.17%
453,686
IVA
58
Inventiva
IVA
$804M
$6.78M 0.14%
1,222,453
+732,453
LRMR icon
59
Larimar Therapeutics
LRMR
$360M
$6.75M 0.14%
+1,500,000
HELP
60
Cybin Inc
HELP
$215M
$6.3M 0.13%
1,313,137
-541,118
BLLN
61
BillionToOne Inc
BLLN
$4.65B
$3.95M 0.08%
50,000
ALGS icon
62
Aligos Therapeutics
ALGS
$32.7M
$3.3M 0.07%
444,110
ANL
63
Adlai Nortye
ANL
$665M
– –
-34,852
BHVN icon
64
Biohaven
BHVN
$1.7B
– –
0
DVAX
65
DELISTED
Dynavax Technologies
DVAX
– –
-15,726,349
MNPR icon
66
Monopar Therapeutics
MNPR
$400M
– –
-95,408
RAPT
67
DELISTED
RAPT Therapeutics
RAPT
– –
-110,448
XBI icon
68
State Street SPDR S&P Biotech ETF
XBI
$8.09B
– –
0
XENE icon
69
Xenon Pharmaceuticals
XENE
$5.04B
– –
-366,435
1 2
3